Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis Pain

NEW YORK& INDIANAPOLIS--(BUSINESS WIRE) March 25, 2021 -- Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced the outcome of the U.S. Food and Drug Administration (FDA) Joint Arthritis Advisory Committee and Drug Safety...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials